Canada Publishes Real World Evidence Guidance For HTA And Regulatory Decision Making
Executive Summary
The new guidance was drawn up through extensive engagement with national and international experts in RWD and RWE, as well as stakeholders in Canada.
You may also be interested in...
National Real-World Evidence Frameworks For HTA Should Be Consistent, Not Identical
Health technology assessment bodies must strike a fine balance between standardizing their real-world evidence frameworks with those of other countries and tailoring them to meet population-specific needs, an expert tells England’s NICE.
Patient Voice To Data: How Novartis Is Listening Up, Harnessing RWE In APMA
Physician-turned-pharma executive, Iris Zemzoum, leads Novartis in the Asia Pacific, Middle East and Africa (APMA) region. She explains how the Swiss group is empowering patients to help shape the future of health care and also partnering across the diverse region to leverage real-world evidence.
Canada Builds On RWE Guidance
Industry representatives are invited to join a new task force to help advise on how industry-gathered real-world evidence should be used in regulatory and health technology assessment decision making.